4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Unresectable Gallbladder Carcinoma: new trials by email Literature Review of Unresectable Gallbladder Carcinoma trials Research Report on Unresectable Gallbladder Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Ramucirumab - Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 61 | 2015-12-29 | 2023-06-15 |
| Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers Cisplatin, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis - Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 | Phase 2 | Completed | M.D. Anderson Cancer Center | 62 | 2015-04-02 | 2022-02-02 |
| MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery Akt Inhibitor MK2206, Diagnostic Laboratory Biomarker Analysis, Pharmacological Study - Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 8 | 2011-04-01 | 2016-06-17 |
| Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Erlotinib Hydrochloride, Sorafenib Tosylate - Extrahepatic Bile Duct Adenocarcinoma, Gallbladder Adenocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2010-04-01 | 2015-06-30 |
Gallbladder Neoplasms (4) · Carcinoma, Hepatocellular (2) · Cholangiocarcinoma (2) · Bile Duct Neoplasms (1) · Klatskin Tumor (1)
Adenocarcinoma (4) · Biliary Tract Diseases (4) · Biliary Tract Neoplasms (4) · Carcinoma (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gallbladder Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Liver Diseases (2) · Liver Neoplasms (2) · Bile Duct Diseases (1) · Cholangiocarcinoma (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Cisplatin (1) · Erlotinib Hydrochloride (1) · Gemcitabine (1) · MK 2206 (1) · Platinum (1) · Ramucirumab (1) · Sorafenib (1) · Taxes (1)
M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2)
United States (4)
Anthony El-Khoueiry (1) · Milind Javle (1) · Rachna T Shroff (1) · Tanios Bekaii-Saab (1)
N01CM00070 (1), P30CA016058 (1), U10CA032102 (1)